Hexarelin – 5mg

Hexarelin is a synthetic hexapeptide and potent agonist of the growth hormone secretagogue receptor (GHS-R1a), the same ghrelin receptor targeted by GHRP-2, though with a distinct potency profile and an additional documented receptor interaction that sets it apart within the GHRP research family. iLab Pharma’s formulation supplies 5mg as a lyophilized vial, preserving peptide structural integrity and potency across storage conditions until reconstitution. Standard practice for GHRPs where aqueous stability at ambient temperature is limited and lyophilized storage maintains compound activity across extended research timelines.

Hexarelin is documented as the most potent GHS-R1a agonist among the synthetic GHRP family; producing greater peak GH secretory responses than GHRP-2 and GHRP-6 at equivalent doses in comparative research studies. This superior potency is attributed to Hexarelin’s structural characteristics that produce particularly strong GHS-R1a binding affinity, making it a frequently selected reference compound in research establishing the upper bounds of GHRP mediated GH secretion and examining maximal GHS-R1a receptor activation responses. Like GHRP-2, Hexarelin stimulates GH release through dual mechanisms. Directly activating pituitary somatotroph cells and simultaneously suppressing hypothalamic somatostatin tone, producing a more robust GH secretory pulse than GHRH receptor activation alone.

Hexarelin’s most pharmacologically distinctive research characteristic is its documented activity at CD36 scavenger receptors in cardiac tissue. A receptor interaction completely independent of GHS-R1a that has generated specific research interest in cardioprotective activity studies. Hexarelin’s CD36 mediated cardiac activity has been investigated in research examining myocardial protection, cardiac function preservation, and anti fibrotic effects in heart tissue; a research dimension that no other GHRP in CSD’s range shares and that positions Hexarelin as a uniquely dual target research compound spanning both GH axis stimulation and direct cardiac receptor activity within a single peptide.

iLab Pharma formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD stocks Hexarelin alongside GHRP-2 and Tesamorelin in the growth hormone secretagogue range, giving researchers access to GHS-R1a agonists across multiple potency profiles and a GHRH receptor agonist for complete GH axis stimulation research coverage from a single verified Canadian supplier. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.

Commonly researched alongside GHRP-2 and CJC-1295 in comparative GH secretagogue and GHS-R1a agonist studies. Browse CSD’s full peptide range for complete sourcing.